Diabetic Retinopathy Screening (DRISTi) (CE Class 1) is an AI product designed to detect the early presence of Diabetic Retinopathy (DR) in patients during eye check up screening process instantaneously.

Our first of a kind patent applied AI Algorithms on a chip as plug in for Medical imaging equipment. Running on mobile device for instant diagnosis in remote places for efficient and affordable point of care diagnostics and increased awareness.

Diabetic retinopathy affects over one third of all people with diabetes and is the leading cause of vision loss. Globally the prevalence of diabetes is increasing rapidly. Since DR is a progressive disease, early stage detection and treatment can save the patient from losing sight. Due to the alarming increase of Diabetic retinopathy the screening for DR every 6 months becomes important to check progression of DR.

Our AI Product Diabetic Retinopathy Screening System is a novel and cost effective screening tool for identifying presence of Diabetic Retinopathy with a Sensitivity and Specificity above 90.

Patient Journey

How it Works

Interested in DRISTi?


The manufacturer has provided CEpartner4U with all necessary documentation, together with an appropriate Declaration of Conformity that the medical devices fulfil the essential requirements of Directive 93/42/EEC. For details please check here


Hansanet is an image quality assessment AI software developed to quantify the gradability of an input image. It is developed using a state-of-the-art deep learning model, that is capable of identifying underlying features using a soft attention mechanism. Hansanet is tailored to run on edge devices such as mobile phones, raspberry pi, etc. Hansanet solves one major issue of ungradable images caused by the inexperienced operators, poor lighting, artifacts, etc, due to which there can be a delay in reporting or in worse scenario false reporting. Using Hansanet, we minimized the failure-rate (inability to click good image) of an operator to zero percent.



How it Works


SAHASTRA brings together the goodness and ease of Healthcare & Support as foreseen by encapsulating, integrating and collaborating multiple Institutions, Doctors and Patients together within a single platform.

SAHASTRA provides a unique and simplified gateway for uploading, processing and consolidating multiple patient screening data across various locations globally.

It helps connecting the providers and healthcare with patient together under one umbrella by providing specific role based assignment for each Genre type, empowering the ability to relate all patient screening records across.

Product Pipeline

Diabetic Retinopathy Detection SystemIn market
Glaucoma detectionIn validation stage
Chest X-rays for pneumonia DetectionIn validation stage
Chest X-rays for TB DetectionIn validation stage
Breast Cancer DetectionIn validation stage
Multiple Sclerosis Serial ReadingIn validation stage
Lung Cancer DetectionIn data gathering stage
Alzheimer's and Parkinson's early DetectionIn data gathering stage